VIVOSIM LABS, INC. (VIVS) Total liabilities 2017–2026
VIVOSIM LABS, INC. (VIVS) total liabilities at each fiscal year-end, per SEC filings.
$8.5MFY2026 · since FY2017: $6.8M → $8.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $8.5M | +104.1% |
| FY2025 | $4.2M | +51.3% |
| FY2024 | $2.7M | -44.9% |
| FY2023 | $5.0M | +61.5% |
| FY2022 | $3.1M | +328.2% |
| FY2021 | $721,000 | -60.2% |
| FY2020 | $1.8M | -58.2% |
| FY2019 | $4.3M | -17.5% |
| FY2018 | $5.2M | -23.1% |
| FY2017 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice